What is GeneDx Holdings's restricted cash?

GeneDx Holdings (WGS) reported restricted cash of $992K in Q1 2026.

How has GeneDx Holdings's restricted cash changed year-over-year?

GeneDx Holdings's restricted cash increased by 0.2% year-over-year, from $990K to $992K.

What is the long-term trend for GeneDx Holdings's restricted cash?

Over 5 years (2020 to 2025), GeneDx Holdings's restricted cash has grown at a 2.0% compound annual growth rate (CAGR), from $900K to $992K.

What does restricted cash mean?

Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

GeneDx Holdings WGS Restricted Cash

Restricted Cash at other companies

Tempus AI, Inc.TEM

$4.69M+172%

Guardant HealthGH

$112.15M+6.5%

Adaptive BiotechnologiesADPT

$2.71M-0.1%

Bio-Rad LaboratoriesBIO

——

RevvityRVTY

——

Agilent TechnologiesA

——

Other financials

Income statement

See full

Revenue$102.3M+17.4%

Gross profit$68.2M+16.6%

Operating income-$57.5M-1,163%

Net income-$63.3M-870%

EPS (diluted)-$2.16-839%

Balance sheet

See full

Cash & equivalents$94.9M-5.7%

Total debt$96.7M+82.5%

Total equity$254.1M-1.3%

Total assets$506.3M+13.4%

Cash flow

See full

Operating cash flow-$32.4M-418%

CapEx$6.5M+5.3%

Free cash flow-$38.9M-1,059%

Valuation

See full

Market cap$1.72B-24.3%

Enterprise value$1.73B-22.8%

P/S3.9×-3.0×

Profitability

See full

Gross margin69.6%+4.3pp

Operating margin-14.9%—

Net margin-17.6%—

FCF margin3.8%+2.1pp

Returns & leverage

See full

Return on equity-30.4%—

Debt / equity0.4×+0.2×

Current ratio3.1×-0.2×

Where this comes from

Reported directly by GeneDx Holdings in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCash.

The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about GeneDx Holdings's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is GeneDx Holdings's restricted cash?: GeneDx Holdings (WGS) reported restricted cash of $992K in Q1 2026.
How has GeneDx Holdings's restricted cash changed year-over-year?: GeneDx Holdings's restricted cash increased by 0.2% year-over-year, from $990K to $992K.
What is the long-term trend for GeneDx Holdings's restricted cash?: Over 5 years (2020 to 2025), GeneDx Holdings's restricted cash has grown at a 2.0% compound annual growth rate (CAGR), from $900K to $992K.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.